New Study from Burst Biologics Featured in Regenerative Medicine Journal

Monday, August 27, 2018 Drug News
Email Print This Page Comment bookmark
Font : A-A+

Biotechnology Company Publishes Groundbreaking Amniotic Membrane Research

BOISE, Idaho, Aug. 27, 2018 /PRNewswire/ -- Burst Biologics is pleased to announce an exciting new milestone: its research

has been featured in the prestigious Regenerative Medicine journal and indexed in PubMed and Medline. Like all articles published in Regenerative Medicine, Burst's placental tissue research paper was reviewed by renowned scientists through a rigorous double-blind peer-review process.

This new research study from Burst Biologics demonstrates the clinical utility of dehydrated amniotic membrane, a placental tissue known for its regenerative properties. It's a significant achievement for Burst's research to be published in Regenerative Medicine, one of the most impactful journals in the "Biomedical Engineering" category.

The Regenerative Medicine publication is edited under Dr. Chris Mason, Professor of Regenerative Medicine in the Advanced Centre for Biochemical Engineering at University College London. Inclusion in the journal requires peer review by two or more members of the International Editorial Board to ensure that the article is scientifically accurate and clinically relevant, and all identities are kept confidential to ensure lack of bias.

"We're pleased that our latest scientific study has been validated by scientists of such stature," said Christopher D. Jones, founder and CEO of Burst Biologics. "Our company will continue advancing the field of regenerative medicine by letting the data guide us toward tomorrow's medical breakthroughs." 

About Burst BiologicsBurst Biologics is a rapidly-growing medical research and biotechnology company providing hospitals and clinicians with a range of powerful regenerative therapies derived from cord blood, placental tissue, and bone. With a commitment to harnessing the power of biology, the research team at Burst Biologics is conducting industry-leading research in areas like musculoskeletal, immuno-oncology, and CNS diseases. Visit the Burst Biologics research page to learn more.

Cision View original content:http://www.prnewswire.com/news-releases/new-study-from-burst-biologics-featured-in-regenerative-medicine-journal-300702191.html

SOURCE Burst Biologics



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store